Totsuka Y - Search Results

1

High malignant transformation rate of widespread multiple oral leukoplakias.

Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Kohgo T, Fukuda H. Saito T, et al. Among authors: totsuka y. Oral Dis. 1999 Jan;5(1):15-9. doi: 10.1111/j.1601-0825.1999.tb00058.x. Oral Dis. 1999. PMID: 10218036

2

Comparison between submucosal (extra-nodal) and nodal non-Hodgkin's lymphoma (NHL) in the oral and maxillofacial region.

Shindoh M, Takami T, Arisue M, Yamashita T, Saito T, Kohgo T, Notani K, Totsuka Y, Amemiya A. Shindoh M, et al. Among authors: totsuka y. J Oral Pathol Med. 1997 Jul;26(6):283-9. doi: 10.1111/j.1600-0714.1997.tb01238.x. J Oral Pathol Med. 1997. PMID: 9234189

3

Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality.

Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H. Saito T, et al. Among authors: totsuka y. Int J Oral Maxillofac Surg. 2001 Feb;30(1):49-53. doi: 10.1054/ijom.2000.0012. Int J Oral Maxillofac Surg. 2001. PMID: 11289621

4

Cytoplasmic expression of HuR may be a valuable diagnostic tool for determining the potential for malignant transformation of oral verrucous borderline lesions.

Habiba U, Kitamura T, Yanagawa-Matsuda A, Hida K, Higashino F, Ohiro Y, Totsuka Y, Shindoh M. Habiba U, et al. Among authors: totsuka y. Oncol Rep. 2014 Apr;31(4):1547-54. doi: 10.3892/or.2014.3017. Epub 2014 Feb 10. Oncol Rep. 2014. PMID: 24534848 Free PMC article.

5

Specific p53 mutations predict poor prognosis in oral squamous cell carcinoma.

Yamazaki Y, Chiba I, Hirai A, Sugiura C, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Fukuda H. Yamazaki Y, et al. Among authors: totsuka y. Oral Oncol. 2003 Feb;39(2):163-9. doi: 10.1016/s1368-8375(02)00064-7. Oral Oncol. 2003. PMID: 12509970

6

Radioresistance in oral squamous cell carcinoma with p53 DNA contact mutation.

Yamazaki Y, Chiba I, Hirai A, Notani K, Kashiwazaki H, Tei K, Totsuka Y, Iizuka T, Kohgo T, Fukuda H. Yamazaki Y, et al. Among authors: totsuka y. Am J Clin Oncol. 2003 Oct;26(5):e124-9. doi: 10.1097/01.coc.0000091352.60347.f8. Am J Clin Oncol. 2003. PMID: 14528086

7

Expression of E1AF, an ets-family transcription factor, is correlated with the invasive phenotype of oral squamous cell carcinoma.

Hida K, Shindoh M, Yoshida K, Kudoh A, Furaoka K, Kohgo T, Fujinaga K, Totsuka Y. Hida K, et al. Among authors: totsuka y. Oral Oncol. 1997 Nov;33(6):426-30. doi: 10.1016/s0964-1955(97)00047-x. Oral Oncol. 1997. PMID: 9509127

8

Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes.

Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, Ono M, Kohgo T, Nakamura M, Notani K, Fukuda H, Totsuka Y, Yoshida K, Fujinaga K. Hanzawa M, et al. Among authors: totsuka y. Carcinogenesis. 2000 Jun;21(6):1079-85. Carcinogenesis. 2000. PMID: 10836994

9

BAG-1 expression correlates highly with the malignant potential in early lesions (T1 and T2) of oral squamous cell carcinoma.

Shindoh M, Adachi M, Higashino F, Yasuda M, Hida K, Nishioka T, Ono M, Takayama S, Reed JC, Imai K, Totsuka Y, Kohgo T. Shindoh M, et al. Among authors: totsuka y. Oral Oncol. 2000 Sep;36(5):444-9. doi: 10.1016/s1368-8375(00)00025-7. Oral Oncol. 2000. PMID: 10964051

10

E1AF expression is closely correlated with malignant phenotype of tongue squamous cell carcinoma through activation of MT1-MMP gene promoters.

Izumiyama Y, Ohiro Y, Higashino F, Yoshida K, Taguchi K, Todo S, Kohgo T, Totsuka Y, Shindoh M. Izumiyama Y, et al. Among authors: totsuka y. Oncol Rep. 2005 Apr;13(4):715-20. Oncol Rep. 2005. PMID: 15756447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters